|
|
|
|
Kewaunee Scientific Corporation (NASDAQ: KEQU) |
|
|
|
| |
KEQU's Revenue Growth by Quarter and Year
Kewaunee Scientific's Revenue results by quarter and year
|
Select the Comparisons :
|
|
Select the Ratio:
|
|
| KEQU Revenue (in millions $) |
FY 2025 |
FY 2024 |
FY 2023 |
FY 2022 |
| 4th Quarter |
April |
-
|
58.64
|
53.99
|
49.72
|
| 3rd Quarter |
January |
66.38
|
46.03
|
60.82
|
40.63
|
| 2nd Quarter |
October |
46.95
|
49.47
|
54.56
|
39.03
|
| 1st Quarter |
July |
47.49
|
48.91
|
50.12
|
39.49
|
| FY |
|
160.82
|
203.05
|
219.49
|
168.87
|
| KEQU Revenue third quarter 2025 Y/Y Growth Comment |
Kewaunee Scientific Corporation achieved in the third quarter 2025, above Company average Revenue rise of 44.21% year on year, to $ 66.38 millions.
Looking into third quarter 2025 results within Laboratory Analytical Instruments industry 11 other companies have achieved higher Revenue growth. While Kewaunee Scientific Corporation' s Revenue jump of 44.21% ranks overall at the positon no. 2166 in the third quarter 2025.
|
| KEQU Revenue ( Y/Y Growth %) |
2025
|
2024 |
2023 |
2022 |
| 4th Quarter |
April |
- |
8.61 % |
8.59 % |
28.44 % |
| 3rd Quarter |
January |
44.21 % |
-24.32 % |
49.69 % |
21.87 % |
| 2nd Quarter |
October |
-5.09 % |
-9.33 % |
39.79 % |
0.08 % |
| 1st Quarter |
July |
-2.9 % |
-2.41 % |
26.92 % |
8.43 % |
| FY |
|
- |
-7.49 % |
29.98 % |
14.51 % |
KEQU Revenue (Quarter on Quarter Growth %) |
2025
|
2024 |
2023 |
2022 |
| 4th Quarter |
April |
- |
27.4 % |
-11.23 % |
22.37 % |
| 3rd Quarter |
January |
41.38 % |
-6.95 % |
11.47 % |
4.1 % |
| 2nd Quarter |
October |
-1.14 % |
1.14 % |
8.86 % |
-1.16 % |
| 1st Quarter |
July |
-19.01 % |
-9.41 % |
0.8 % |
2.01 % |
| FY (Year on Year) |
|
- |
-7.49 % |
29.98 % |
14.51 % |
| Revenue Y/Y Growth Statistics |
| High |
Average |
Low |
| 36.33 % |
5.28 % |
-13.58 % |
| (Jan 31 2023) |
|
(Jul 31 2019) |
|
|
| Revenue Y/Y Growth Statistics |
| High |
Average |
Low |
| 36.33 % |
5.28 % |
-13.58 % |
| (Jan 31 2023) |
|
(Jul 31 2019) |
|
| Revenue by Quarter for the Fiscal Years 2022, 2023, 2024, 2025 |
Kewaunee Scientific's Q/Q Revenue Growth
| Revenue Q/Q Growth Statistics |
| High |
Average |
Low |
| 41.38 % |
0.55 % |
-100 % |
| (Jan 31 2025) |
|
|
| KEQU's III. Quarter Q/Q Revenue Comment |
Kewaunee Scientific Corporation achieved in the III. Quarter 2025 above company average sequential Revenue jump of 41.38%, to $ 66.38 millions, from $46.95 millions in the second quarter.
Laboratory Analytical Instruments company is impressively improving, not just claiming higher then normal increase, and additionally increasing pace.
Within Laboratory Analytical Instruments industry Kewaunee Scientific Corporation achieved highest sequential Revenue growth. While Kewaunee Scientific's Revenue growth quarter on quarter, overall rank is 389. |
|
|
|
| Revenue Q/Q Growth Statistics |
| High |
Average |
Low |
| 41.38 % |
0.55 % |
-100 % |
| (Jan 31 2025) |
|
|
| KEQU's III. Quarter Q/Q Revenue Comment |
Kewaunee Scientific Corporation achieved in the III. Quarter 2025 above company average sequential Revenue jump of 41.38%, to $ 66.38 millions, from $46.95 millions in the second quarter.
KEQU is impressively improving, with recording above average growth, and also accelerating pace,Most analysts added.
Within Laboratory Analytical Instruments industry Kewaunee Scientific Corporation achieved highest sequential Revenue growth. While Kewaunee Scientific's Revenue growth quarter on quarter, overall rank is 389. |
|
Kewaunee Scientific's 12 Months Revenue Growth Year on Year
Revenue TTM Growth |
12 Months Ending
(Jan 31 2025) |
12 Months Ending
(Oct 31 2024) |
12 Months Ending
(Jul 31 2024) |
12 Months Ending
(Apr 30 2024) |
12 Months Ending
(Jan 31 2024) |
| Cumulative Revenue 12 Months Ending |
$ 219.46 |
$ 199.11 |
$ 201.63 |
$ 203.05 |
$ 198.40 |
| Y / Y Revenue Growth (TTM) |
10.62 % |
-6.6 % |
-7.63 % |
-7.49 % |
-7.82 % |
| Year on Year Revenue Growth Overall
Ranking |
# 2767 |
# 1122 |
# 578 |
# 340 |
# 196 |
| Seqeuential Revenue Change (TTM) |
10.22 % |
-1.25 % |
-0.7 % |
2.35 % |
-6.94 % |
| Seq. Revenue Growth (TTM) Overall
Ranking |
# 2722 |
# 2160 |
# 1988 |
# 1490 |
# 759 |
| Cumulative Revenue growth Comment |
Kewaunee Scientific saw improvement in Revenue growth trend, posting cumulative 12 months Revenue growth of 10.62% year on year, to $ 219 millions if the fiscal year would have ended in Jan 31 2025.
Kewaunee Scientific's trailing twelve months Revenue growth was higher than company's average 5.28% and higher than -6.6% growth in Oct 31 2024.
But from twelve months ended Oct 31 2024 increase was slower at 10.22 % from $199.11 millions recorded in twelve months ending a quarter Oct 31 2024.
Yet this was evidence of positive momentum, while the usual sequential Revenue advancement lays at 5.28%.
The momentum was even more impressive from the previous reporting period exhibited at 10.22 % jump from $199.11 millions in twelve months ending a quarter before.
In the Healthcare sector 391 other companies have achieved higher trailing twelve month Revenue growth. While Revenue growth total ranking has deteriorated compare to previous quarter from 1122 to 2767. |
|
|
| Revenue TTM Y/Y Growth Statistics |
| High |
Average |
Low |
36.33 % |
5.28 % |
-13.58 % |
|
|
|
| Revenue TTM Q/Q Growth Company Ranking |
| Within: |
No. |
| Industry |
# 16 |
| Sector |
# 387 |
| S&P 500 |
# 2722 |
|
| Cumulative Revenue growth
Comment |
Kewaunee Scientific saw improvement in Revenue growth trend, posting cumulative 12 months Revenue growth of 10.62% year on year, to $ 219 millions if the fiscal year would have ended in Jan 31 2025.
Kewaunee Scientific's trailing twelve months Revenue growth was higher than company's average 5.28% and higher than -6.6% growth in Oct 31 2024.
But from the previous reporting period rise was less at 10.22 % from $199.11 millions reported in twelve months ending a quarter Oct 31 2024 added on.
Yet it was validation of positive momentum, while the average sequential growth is at 5.28%.
The progress was even more impressive sequentially exhibited at 10.22 % rise from $199.11 millions in twelve months ending a quarter Oct 31 2024.
In the Healthcare sector 391 other companies have achieved higher trailing twelve month Revenue growth. While Revenue growth total ranking has deteriorated compare to previous quarter from 1122 to 2767. |
| Revenue TTM Y/Y Growth Statistics |
| High |
Average |
Low |
36.33 % |
5.28 % |
-13.58 % |
|
|
|
| Revenue TTM Q/Q Growth Company Ranking |
| Within: |
No. |
| Industry |
# 16 |
| Sector |
# 387 |
| S&P 500 |
# 2722 |
|
|
CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.
Copyright © 2025 CSIMarket, Inc. All rights
reserved.
Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
44.21%